Fortress Biotech Completes Asset Acquisition/Disposition
Ticker: FBIOP · Form: 8-K · Filed: Jun 5, 2025 · CIK: 1429260
Sentiment: neutral
Topics: acquisition, disposition, assets
Related Tickers: FBIO
TL;DR
FBIO closed an asset deal on 5/30, check the 8-K for details.
AI Summary
Fortress Biotech, Inc. filed an 8-K on May 30, 2025, reporting the completion of an acquisition or disposition of assets. The filing also includes financial statements and exhibits related to this event. The company is incorporated in Delaware and its fiscal year ends on December 31.
Why It Matters
This filing indicates a significant corporate event for Fortress Biotech, potentially impacting its asset base and financial structure.
Risk Assessment
Risk Level: medium — Acquisitions and dispositions of assets can introduce significant financial and operational risks.
Key Players & Entities
- Fortress Biotech, Inc. (company) — Registrant
- May 30, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 1111 Kane Concourse, Suite 301 (address) — Business and Mail Address
- Bay Harbor Islands, FL 33154 (address) — Business and Mail City, State, Zip
FAQ
What specific assets were acquired or disposed of by Fortress Biotech?
The filing does not specify the exact assets involved in the acquisition or disposition, only that the event was completed on May 30, 2025.
What is the financial impact of this asset transaction on Fortress Biotech?
The filing indicates the completion of the transaction and includes financial statements and exhibits, but does not detail the specific financial impact in the provided text.
When was Fortress Biotech, Inc. incorporated?
Fortress Biotech, Inc. was incorporated in Delaware.
What is the primary business of Fortress Biotech, Inc.?
Fortress Biotech, Inc. operates in the Pharmaceutical Preparations industry, SIC code 2834.
What is the fiscal year end for Fortress Biotech, Inc.?
The fiscal year end for Fortress Biotech, Inc. is December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 5, 2025 regarding Fortress Biotech, Inc. (FBIOP).